What is Manus Bio?
Manus Bio is at the forefront of industrial biomanufacturing, utilizing cutting-edge biological advancements to produce complex natural products. These products serve a wide array of consumer and industrial markets, including flavors, fragrances, food ingredients, cosmetics, vitamins, pharmaceuticals, and agricultural chemicals. By recreating natural processes through advanced fermentation technology, Manus Bio offers sustainable and cost-effective sourcing solutions for essential goods, positioning itself as a key player in the next-generation biomanufacturing landscape.
How much funding has Manus Bio raised?
Manus Bio has raised a total of $103.8M across 4 funding rounds:
Private Equity
$9.1M
Series A
$19.4M
Debt
$350K
Series B
$75M
Private Equity (2017): $9.1M, investors not publicly disclosed
Series A (2018): $19.4M led by Venture Capital and NXT Ventures
Debt (2020): $350K supported by PPP
Series B (2020): $75M featuring BBGI Public Company Limited
Key Investors in Manus Bio
Ventech
Ventech is a venture capital firm specializing in high-growth European startups within the digital economy, including enterprise software and deep technology. Their investment in Manus Bio suggests a focus on innovative, scalable technology platforms.
NXT Ventures
NXT Capital provides structured financing solutions to the U.S. middle market, managing an asset platform for institutional investors. Their participation indicates a strategic financial backing for Manus Bio's growth phase.
BBGI Public Company Limited
BBGI Public Company Limited's involvement suggests a significant strategic partnership or investment, potentially aligning with Manus Bio's expansion into global markets or specific product verticals.
What's next for Manus Bio?
The substantial enterprise-level funding, particularly the recent strategic investment, indicates Manus Bio is poised for significant scaling and market expansion. This capital infusion will likely fuel advancements in their proprietary fermentation technology, enabling the company to broaden its product portfolio and penetrate new markets. The focus on sustainable and cost-effective biomanufacturing suggests a strategic direction towards capturing market share from traditional chemical synthesis methods, driving growth in the health, wellness, and nutrition sectors.
See full Manus Bio company page
